In both acute and chronic pain conditions, women tend to be more sensitive than men. This sex difference may be regulated by estrogens, such as estradiol, that are synthesized in the spinal cord and brainstem and act locally to influence pain processing. To identify a potential cellular source of local estrogen, here we examined the expression of aromatase, the enzyme that catalyzes the con- 
The earlier work that characterized the distribution of aromatase used antibodies directed against the protein. Because of significant concerns with antibody specificity, here we took advantage of a transgenic mouse line in which an internal ribosome entry site coupled to a nuclear lacZ reporter has been knocked into the aromatase gene (Wu et al., 2009) , allowing for very precise molecular mapping of the distribution of aromatase-expressing cells. We also characterized the cells based on co-expression of a host of molecular markers and examined the extent to which these cells are influenced in different mouse models of acute and chronic pain.
| M E TH ODS

| Mouse lines
We used aromatase IRES-PLAP-IRES-nlacZ reporter mice (Wu et al., 2009 ; homozygous for reporter allele, RRID:MGI:4430066 and heterozygous for reporter allele, RRID:MGI:5634564). Animals were 8-12 weeks old at time of perfusion. All experiments were performed in accordance with the University of California, San Francisco's Institutional Animal Care and Use Committee guidelines.
| Immunohistochemistry
Animals were deeply anesthetized using 250-400 mg/kg 2,2,2-Tribromoethanol (Avertin, Sigma-Aldrich, St. Louis, Missouri) and then transcardially perfused with 10 ml of phosphate-buffered saline (PBS) followed by 30 ml of 4% formaldehyde in PBS (37% formaldehyde diluted 1/10; ACROS Organics, Morris Plains, New Jersey). All perfusions and incubations used 1X PBS with the exception of those involving staining for sst2a, which required PBS containing 300 mM NaCl rather than the typical concentration of 137 mM NaCl. Dorsal root ganglia (DRGs), trigeminal ganglia (TGs), spinal cord, and brain were dissected out and post-fixed in 4% formaldehyde in PBS for 3-6 hr at room temperature. Tissue was cryo-protected in 30% sucrose for at least one night and then sectioned on a cryostat; spinal cord and medulla were cut at a thickness of 25 and 35 mm, respectively, and collected in PBS while DRG and TG were cut at 14 mm and directly mounted onto slides. For staining, tissue was blocked for 1 hr in 10% normal goat serum in PBS containing 0.3% Triton X-100 and then incubated overnight at room temperature in primary antibodies diluted in 1% normal goat serum in PBS containing 0.3% Triton X-100. Primary antibodies used are as indicated in Table 1 . Following overnight incubation, tissue was washed three times with PBS and then incubated with secondary antibodies diluted 1:1,000 in PBS for a minimum of 2 hr at room temperature. Secondary antibodies were all Alexa Fluor 488, 546, 594, Waltham, Massachusetts) and raised in goat against the appropriate primary species.
After several PBS washes, tissue was mounted onto slides (if necessary) and allowed to briefly dry before coverslipping with Fluoromount-G aqueous mounting medium (SouthernBiotech, Birming- ham, Alabama). showing that immunoreactivity is present in neurons and in nervous tissue but not in glia or in other organs (Mullen, Buck, & Smith, 1992 (Kardon et al., 2014; Punnakkal, von Schoultz, Haenraets, Wildner, & Zeilhofer, 2014) . In addition, for this particular antibody, Western blot from human fetal kidney tissue recognizes a band at the proper expected size of 45 kDa (manufacturer's information). Furthermore, immunostaining in aromatase reporter mice that were crossed to a GAD67-GFP reporter line indicate that around 80% of the aromatase cells are GABAergic, which is similar to the percentage of aromatase cells that are Pax2-expressing (data not shown).
Guinea pig anti sst2a (Gramsch Laboratories, Cat# SS-870, RRID: AB_2491104) has been previously shown to label inhibitory neurons in the rodent spinal cord dorsal horn (Todd, Spike, & Polg ar, 1998) and in a pattern that matches other reports of sst2a expression (Holloway, Feniuk, Kidd, & Humphrey, 1996; Schindler, Sellers, Humphrey, & Emson, 1997) . Specificity of this antibody has been confirmed through dot-blot assays demonstrating detection of sst2a but not somatostatin receptors sst1, sst2b, or sst3; Western blots from rat brain tissue displaying a broad band of suitable size (80 kDa); and lack of immunoreactive cells following preadsorption with the immunizing peptide (Schulz et al., 1998) . Antibody was kindly provided by Andrew J. Todd, University of Glasgow.
Guinea pig anti Lmx1b (gift of T. M€ uller and C. Birchmeier, MaxDelbr€ uck-Center for Molecular Medicine; Berlin, Germany, RRID: AB_2314752) specifically marks excitatory dorsal horn interneurons of the dI5 and dILB lineages (Yang, Cagle, & Honig, 2010) . The staining pattern in our report is consistent with previously published articles (Del Barrio et al., 2013; Szabo et al., 2015) .
Rabbit anti ERa (Millipore, Cat# 06-935, RRID:AB_310305) detects in Western blots a roughly 58 kDa band from MCF7 cell lysate (manufacturer's information) and a 55 kDa band from cichlid whole brain extract (Munchrath & Hofmann, 2010) . Preincubation with the antigen eliminates all bands (Friend, Resnick, Ang, & Shupnik, 1997) . In addition, there was no detectable signal in spinal cord tissue immunostained from ERa conditional knockout mice (unpublished observation).
Rabbit anti c-Fos (Calbiochem, Cat# PC38, RRID:AB_2106755) labels c-Fos without cross-reactivity with other Fos-related antigens in the rat central nervous system (Hoffman, Smith, & Fitzsimmons, 1992; Rinaman, Verbalis, Stricker, & Hoffman, 1993 (Yamanaka, Kobayashi, Okubo, Fukuoka, & Noguchi, 2011) . Our data show that ATF3 is only induced in neurons ipsilateral to the nerve injury, which is in agreement with previous studies (Br az & Basbaum, 2010; Guan et al., 2016; Tsujino et al., 2000) .
Rabbit anti Iba1 (Wako, Cat# 019-19741, RRID:AB_839504) has been used extensively as a microglia marker and the spinal cord staining pattern we observed is consistent with other reports (Guan et al., 2016; Pineau & Lacroix, 2007; Yamanaka et al., 2011) . This antibody has been demonstrated to be specific to microglia as Western blotting displays a single band of correct expected size of 17 kDa only in microglia-containing tissue samples and immunohistochemistry detects no signal in astrocytes, oligodendrocytes, or neurons (manufacturer's information; Imai, Ibata, Ito, Ohsawa, & Kohsaka, 1996; Ito et al., 1998; Yamanaka et al., 2011) .
| Retrograde tracing
Under intraperitoneal 80-100 mg/kg ketamine 1 5-10 mg/kg xylazine anesthesia, mice were placed in stereotaxic apparatus (Kopf Instruments, Tujunga, California) and 0.5-1 ml of either Fluoro-Gold (Fluorochrome, Denver, Colorado) or red RetroBeads (Lumafluor, Durham, North Carolina) was injected into the left lateral parabrachial nucleus.
Lateral parabrachial nucleus was located according to coordinates from Paxinos and Franklin's The Mouse Brain in Stereotaxic Coordinates. Animals were perfused 3-9 days later and tissue was processed for immunohistochemistry.
| Fos induction
Capsaicin (Sigma-Aldrich; 5 mg in 30 ml saline with 10% Tween-80 and 10% ethanol for cheek, 3 mg in 10 ml saline with 10% Tween-80 and 10% ethanol for hindpaw), 2% formalin (37% by weight formaldehyde, diluted 1/50 in saline; 50 ml for cheek, 10 ml for hindpaw), or chloroquine (chloroquine diphosphate salt, Sigma-Aldrich; 200 mg in 50 ml saline for cheek, 40 mg in 20 ml saline for hindpaw) was injected into the left cheek (shaved the day before injection) or the plantar surface of the left hindpaw of mice that were lightly restrained with a towel.
90 min later, mice were perfused and tissue was processed for immunohistochemistry as above.
| Chronic injury models
For infraorbital or sciatic nerve transection, mice were anesthetized in the same manner as they were for retrograde tracing experiments. The left cheek or left hind leg was shaved, a small incision was made in the whisker pad area or thigh, and then the appropriate nerve was exposed. Following the cutting of the nerve (and in the case of sciatic nerve transection, excision of 2 mm of nerve), cheek or leg was sutured and mice were allowed to recover from anesthesia. One week later, mice were perfused and tissue was processed for immunohistochemistry. For Complete Freund's adjuvant (CFA) injections, mice were lightly restrained with a towel and 20 ml of CFA (Sigma-Aldrich; 1:1 emulsion in saline) was injected into the left cheek or the plantar surface of the left hindpaw. Three days later, mice were perfused and tissue was processed for immunohistochemistry.
| Confocal and epifluorescent imaging
All images except medulla images were taken on a LSM 700 confocal microscope (Zeiss, Oberkochen, Germany) equipped with 405, 488, 555, and 639 nm diode lasers, a main dichroic beam splitter URGB and a gra- liers" filter in Fiji/ImageJ was applied to digitally remove artifacts and debris in areas outside of the tissue. This filter was set to sample the value of pixels in a 100-pixel radius and replace pixels that were more than 10 units brighter than the median with the median value. 
| Quantification of double-labeled cells
| Statistical analysis
Unpaired (Student's) t tests and two-way ANOVA with Tukey's test to correct for multiple comparisons were run using GraphPad Prism (version 6.0e, https://www.graphpad.com/scientific-software/prism, RRID: . We observed a comparable pattern, although with many fewer cells, in laminae I and V of the spinal cord dorsal horn (Figure 2a, b) , which receives nociceptive input from primary sensory neurons of the dorsal root ganglion (DRG; Adrian, 1928; Foerster, 1933) .
Interestingly, we also found scattered aromatase-positive cells in the nucleus of the solitary tract (NST; Figure 1a ), which receives input from nodose ganglion-derived visceral afferents (Contreras, Beckstead, & Norgren, 1982; Randich & Gebhart, 1992) . (Basbaum, 1974; Br az et al., 2011; Coderre, Grimes, & Melzack, 1986; Villar et al., 1989; Wall et al., 1979) . As expected, we recorded activating transcription factor 3 (ATF3), a marker of injured sensory neurons (Br az & Basbaum, 2010; Tsujino et al., 2000) , in large numbers of TG and L4/L5 DRG neurons ipsilateral to the transection (Figure 8a, c, upper right) . However, we never detected b-gal signal in 
| Algogen-and pruritogen-induced Fos expression
| D I SCUSSION
In the present study, we identified and characterized a subpopulation As some of these neurons express Fos in response to a variety of proalgesic or pruritic agents, it is likely that they are engaged in the setting of acute pain and itch. In contrast, their contribution in chronic pain models is unclear, given that we found no difference in the number or pattern of aromatase expressing neurons in several models of nerve or tissue injury. Finally, across the tissues and conditions examined, we found no difference in numbers of aromatase neurons in male and female mice.
| Studies of aromatase expression and technical considerations
Aromatase is a member of the very large and structurally similar cytochrome P450 superfamily (Danielson, 2002) . As a result, it can be difficult to generate antibodies that selectively recognize aromatase without crossreacting with any of the other 101 cytochrome P450 genes in the mouse (Nelson et al., 2004) . In fact, this potential limitation of an immunocytochemical approach is what motivated several groups to develop reporter mouse lines (Wu et al., 2009; Stanić et al., 2014) . In our experiments, we used the mouse generated by Wu and colleagues, which drives b-galactosidase expression under the control of aromatase promoters without disrupting normal aromatase function.
Importantly, b-gal immunostaining in this reporter mouse successfully recapitulates the brain aromatase in situ hybridization pattern (Unger et al., 2015; Wu et al., 2009 ).
Our results using the aromatase reporter mouse are largely consistent with previous immunocytochemical reports of aromatase expression in the medullary and spinal cord dorsal horns in the Japanese quail, rat, and mouse (Horvath & Wikler, 1999; Evrard et al., 2000; O'Brien, Smeester, Michlitsch, Lee, & Beitz, 2015; Smeester, O'Brien, Michlitsch, Lee, & Beitz, 2016) . On the other hand, although our finding that these cells are indeed neurons agrees with the conclusion of some groups (Horvath & Wikler, 1999; Evrard et al., 2000) , it is at odds with another group that concluded that aromatase expression arises from astrocytes (O'Brien et al., 2015; Smeester et al., 2016) . Furthermore, our finding of no expression of aromatase in sensory neurons contrasts significantly with the report of Schaeffer et al. (2010) that described aromatase immunoreactivity in DRG neurons using a mouse monoclonal antibody.
| Neuronal estrogen and pain processing
Aromatase catalyzes the final steps that convert androgens, such as testosterone, to estrogens, such as estradiol. The presence of aromatase expression in spinal and medullary neurons thus indicates that these neurons are capable of synthesizing estrogens. As both the spinal and medullary dorsal horns express estrogen receptors (Amandusson, Hermanson, & Blomqvist, 1995; Bereiter, Cioffi, & Bereiter, 2005; Dun et al., 2009; Merchenthaler, Lane, Numan, and Dellovade, 2004; Shughrue, Lane, & Merchenthaler, 1997; Vanderhorst, Gustafsson, & Ulfhake, 2005) Despite the abundance of superficial dorsal horn interneurons that express estrogen receptors, there is surprisingly little information as to the function of local estrogen synthesis in nociception. When applied to neurons, estrogen increases intrinsic excitability and excitatory transmission (Woolley, 2007) , which suggests that local estrogen would be pronociceptive, promoting sensitization of circuits and subsequent heightened responses to painful stimuli. Indeed, for acute pain, estrogen synthesized in the spinal cord appears to be pronociceptive (Evrard & Balthazart, 2004; Zhang, L€ u, et al., 2012; Zhang, Xiao, et al., 2012) .
Injection of estrogen into the paw, which would mimic the effects of locally synthesized estrogen acting on primary afferents, also generates hyperalgesia (Hucho, Dina, Kuhn, & Levine, 2006; Kuhn et al., 2008) . In contrast, there is evidence that sensory neuron-derived estrogen is antinociceptive (Fusi et al., 2014) . There is also a lack of agreement as to estrogen's function in chronic pain models. It is of interest, for example, that some dorsal horn ERa-expressing neurons can synthesize enkephalin, an endogenous opioid peptide, and that its precursor, preproenkephalin, is acutely upregulated by estrogen (Amandusson, Hallbeck, Hallbeck, Hermanson, & Blomqvist, 1999; Amandusson et al., 1995) . As such, estrogen synthesized by medullary and spinal aromatase-expressing cells could activate ERa-expressing neurons to engage a spinal endogenous analgesic system. On the other hand, although antinociceptive effects of primary afferent and spinal cordderived estrogen were demonstrated in two neuropathic pain models (Ghorbanpoor et al., 2014; Schaeffer et al., 2010) , a different group observed a pronociceptive effect in a bone cancer pain model (O'Brien et al., 2015; Smeester et al., 2016) . Surprisingly, although aromatase expression was increased in each of these chronic pain models, using the reporter mouse we found no changes after nerve or tissue injury.
Although these results are seemingly contradictory, the effects of estrogen are highly dependent on the anatomical location, the type of pain that is assessed, and a host of other factors, making direct comparison of studies difficult (Amandusson & Blomqvist, 2013; Craft, 2007) .
The contribution of local estrogen to pain processing may also depend on the sex of the animal studied. In the rodent brain, aromatase neurons exhibit differential expression in males and females and contribute to sexually dimorphic behaviors, in part through the action of locally synthesized estrogen (Unger et al., 2015; Wu et al., 2009 Duan et al., 2014; Foster et al., 2015; Kardon et al., 2014; Petitjean et al., 2015; Ross et al., 2010) . The sst The Fos results also raise important questions about a possible dual estrogenic and inhibitory function of the aromatase-expressing neurons. On one hand, by converting androgens to estrogens via aromatase, these cells may be producing estrogen that increases the excitability of neighboring neurons (Woolley, 2007) . On the other hand, because the majority of these cells also express inhibitory markers, they likely release GABA, which would reduce activity of neurons with which they communicate. These seemingly conflicting actions suggest that the aromatase-expressing neurons can concurrently regulate different cell populations by both inhibitory and facilitatory mechanisms. Pharmacological studies that block both estrogen synthesis and inhibitory neurotransmission by these cells could elucidate the functional consequences of a dorsal horn neuron releasing two opposing signaling molecules.
| C ONC LUSI ON
Several groups have suggested that estrogen is synthesized in pain processing areas and contributes to pain. In pursuit of the mechanisms that underlie pain-related local estrogen synthesis, this report represents the first attempt to define the molecular identity of the estrogenproducing cells. We demonstrate that aromatase-expressing cells in the spinal cord and medulla, including the neurons of the nucleus of the solitary tract, are anatomically positioned to receive somatic and visceral nociceptive inputs and have the potential to regulate multiple functions, not only through their capacity to release steroids but also through their neurochemical composition, as they form a distinct subpopulation of inhibitory interneurons. Determining whether the estrogenic and inhibitory components work independently or in concert with each other should generate valuable insights into how these cells exert their influence on nociception.
